Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

[1]  J. Yokota,et al.  MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1. , 2014, Cancer discovery.

[2]  Yuhua Sun,et al.  Extraembryonic signals under the control of MGA, Max, and Smad4 are required for dorsoventral patterning. , 2014, Developmental cell.

[3]  Bruno Amati,et al.  Genome recognition by MYC. , 2014, Cold Spring Harbor perspectives in medicine.

[4]  Medical Faculty,et al.  High-Resolution Genomic Profiling of Chronic Lymphocytic Leukemia Reveals New Recurrent Genomic Alterations , 2014 .

[5]  P. Hellman,et al.  MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours , 2014, Familial Cancer.

[6]  S. Dalton,et al.  Roles for MYC in the establishment and maintenance of pluripotency. , 2013, Cold Spring Harbor perspectives in medicine.

[7]  P. Leoni,et al.  Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome. , 2013, Leukemia research.

[8]  P. Gallant.  Myc function in Drosophila. , 2013, Cold Spring Harbor perspectives in medicine.

[9]  D. Ayer,et al.  Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks. , 2013, Cold Spring Harbor perspectives in medicine.

[10]  C. Dang.  MYC, metabolism, cell growth, and tumorigenesis. , 2013, Cold Spring Harbor perspectives in medicine.

[11]  D. Ayer,et al.  MondoA senses adenine nucleotides: transcriptional induction of thioredoxin-interacting protein. , 2013, The Biochemical journal.

[12]  Chung-Hyun Cho,et al.  Mad1 mediates hypoxia-induced doxorubicin resistance in colon cancer cells by inhibiting mitochondrial function. , 2013, Free radical biology & medicine.

[13]  Francesco Bertoni,et al.  MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia , 2013, Leukemia & lymphoma.

[14]  P. Auvinen,et al.  Mondo/ChREBP-Mlx-Regulated Transcriptional Network Is Essential for Dietary Sugar Tolerance in Drosophila , 2013, PLoS genetics.

[15]  Ezekiel J. Maier,et al.  Role of Fat Body Lipogenesis in Protection against the Effects of Caloric Overload in Drosophila* , 2013, The Journal of Biological Chemistry.

[16]  P. Hurlin,et al.  MYC needs MNT , 2013, Cell cycle.

[17]  C. Dang,et al.  Unlocking the mysterious mechanisms of Myc , 2013, Nature Medicine.

[18]  J. Maris,et al.  ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. , 2012, Cancer cell.

[19]  Colin J. Daniel,et al.  A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis , 2012, Proceedings of the National Academy of Sciences.

[20]  N. McCarthy.  Tumorigenesis: Megaphone MYC , 2012, Nature Reviews Cancer.

[21]  D. Green,et al.  c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells , 2012, Cell.

[22]  G. Evan,et al.  All Things to All People , 2012, Cell.

[23]  Charles Y. Lin,et al.  Transcriptional Amplification in Tumor Cells with Elevated c-Myc , 2012, Cell.

[24]  S. Burdach,et al.  MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survival. , 2012, Leukemia research.

[25]  V. Hietakangas,et al.  Glucose sensing by ChREBP/MondoA-Mlx transcription factors. , 2012, Seminars in cell & developmental biology.

[26]  A. F. Stewart,et al.  ChREBP Mediates Glucose-Stimulated Pancreatic β-Cell Proliferation , 2012, Diabetes.

[27]  W. Atchley,et al.  A Novel N-Terminal Domain May Dictate the Glucose Response of Mondo Proteins , 2012, PloS one.

[28]  M. Urioste,et al.  MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma , 2012, Clinical Cancer Research.

[29]  P. Saha,et al.  Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity , 2012, Diabetologia.

[30]  T. Fan,et al.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. , 2012, Cell metabolism.

[31]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[32]  S. Lowe,et al.  RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia , 2011, Nature.

[33]  W. Atchley,et al.  Evolution of the Max and Mlx Networks in Animals , 2011, Genome biology and evolution.

[34]  Sung‐Min Ahn,et al.  Integrated Expression Profiling and Genome-Wide Analysis of ChREBP Targets Reveals the Dual Role for ChREBP in Glucose-Regulated Gene Expression , 2011, PloS one.

[35]  Y. Okazaki,et al.  Indefinite self-renewal of ESCs through Myc/Max transcriptional complex-independent mechanisms. , 2011, Cell stem cell.

[36]  Peder E. Z. Larson,et al.  13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. , 2011, Cell metabolism.

[37]  J. Benítez,et al.  Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma , 2011, Nature Genetics.

[38]  D. Ayer,et al.  An extended Myc network contributes to glucose homeostasis in cancer and diabetes. , 2011, Frontiers in bioscience.

[39]  Susan L Young,et al.  Premetazoan ancestry of the Myc-Max network. , 2011, Molecular biology and evolution.

[40]  N. Vasilevsky,et al.  OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen‐stimulated T cells leading to an increase in cell survival , 2011, European journal of immunology.

[41]  C. Dang,et al.  Therapeutic targeting of Myc-reprogrammed cancer cell metabolism. , 2011, Cold Spring Harbor symposia on quantitative biology.

[42]  Stuart H. Orkin,et al.  A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs , 2010, Cell.

[43]  H. Towle,et al.  Activation and repression of glucose-stimulated ChREBP requires the concerted action of multiple domains within the MondoA conserved region. , 2010, American journal of physiology. Endocrinology and metabolism.

[44]  Fionnuala Morrish,et al.  Myc-dependent Mitochondrial Generation of Acetyl-CoA Contributes to Fatty Acid Biosynthesis and Histone Acetylation during Cell Cycle Entry* , 2010, The Journal of Biological Chemistry.

[45]  Daniel Merl,et al.  Lactic Acidosis Triggers Starvation Response with Paradoxical Induction of TXNIP through MondoA , 2010, PLoS genetics.

[46]  D. Ayer,et al.  Coordination of glucose and glutamine utilization by an expanded Myc network , 2010, Transcription.

[47]  D. Ayer,et al.  Myc, mondo, and metabolism. , 2010, Genes & cancer.

[48]  E. Prochownik,et al.  c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes. , 2010, Molecular endocrinology.

[49]  D. Ayer,et al.  Glucose Controls Nuclear Accumulation, Promoter Binding, and Transcriptional Activity of the MondoA-Mlx Heterodimer , 2010, Molecular and Cellular Biology.

[50]  D. Felsher,et al.  MYC as a regulator of ribosome biogenesis and protein synthesis , 2010, Nature Reviews Cancer.

[51]  Christopher B. Burge,et al.  c-Myc Regulates Transcriptional Pause Release , 2010, Cell.

[52]  C. Liu,et al.  Chromatin remodeling: recruitment of histone demethylase RBP2 by Madl for transcriptional repression of a Myc target gene, telomerase reverse transcriptase , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  Chi V Dang,et al.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. , 2010, Cancer research.

[54]  G. Semenza,et al.  Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression , 2010, Proceedings of the National Academy of Sciences.

[55]  C. Thompson,et al.  The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation , 2009, Proceedings of the National Academy of Sciences.

[56]  P. Gallant,et al.  Myc’s secret life without Max , 2009, Cell cycle.

[57]  Hisashi Tanaka,et al.  Gene Regulation and Epigenetic Remodeling in Murine Embryonic Stem Cells by c-Myc , 2009, PloS one.

[58]  C. Dang,et al.  MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities , 2009, Clinical Cancer Research.

[59]  K. Jones,et al.  SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. , 2009, Molecular cell.

[60]  D. Ayer,et al.  Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity , 2009, Proceedings of the National Academy of Sciences.

[61]  Xudong Dai,et al.  MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT , 2009, Cell cycle.

[62]  Stephen Dalton,et al.  The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. , 2009, Cell stem cell.

[63]  A. Shalev,et al.  Glucose-stimulated Expression of Txnip Is Mediated by Carbohydrate Response Element-binding Protein, p300, and Histone H4 Acetylation in Pancreatic Beta Cells* , 2009, The Journal of Biological Chemistry.

[64]  J. León,et al.  Inhibition of cell differentiation: A critical mechanism for MYC-mediated carcinogenesis? , 2009, Cell cycle.

[65]  Tsung-Cheng Chang,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.

[66]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[67]  E. Guccione,et al.  Analysis of Myc-Induced Histone Modifications on Target Chromatin , 2008, PloS one.

[68]  W. Kaelin.  The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer , 2008, Nature Reviews Cancer.

[69]  R. Eisenman,et al.  Myc's broad reach. , 2008, Genes & development.

[70]  J. Sedivy,et al.  Myc Inhibits p27-Induced Erythroid Differentiation of Leukemia Cells by Repressing Erythroid Master Genes without Reversing p27-Mediated Cell Cycle Arrest , 2008, Molecular and Cellular Biology.

[71]  Bin Tean Teh,et al.  Inhibition of Mxi1 suppresses HIF-2α-dependent renal cancer tumorigenesis , 2008 .

[72]  M.-H. Lee,et al.  Roles of p53, Myc and HIF-1 in Regulating Glycolysis — the Seventh Hallmark of Cancer , 2008, Cellular and Molecular Life Sciences.

[73]  P. Gallant,et al.  Max-independent functions of Myc in Drosophila melanogaster , 2008, Nature Genetics.

[74]  H. Towle,et al.  Glucose Activates ChREBP by Increasing Its Rate of Nuclear Entry and Relieving Repression of Its Transcriptional Activity* , 2008, Journal of Biological Chemistry.

[75]  R. Cencic,et al.  c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. , 2008, Cancer research.

[76]  J. Boult,et al.  Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network , 2008, British Journal of Cancer.

[77]  Yukio Horikawa,et al.  ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. , 2008, Endocrine journal.

[78]  D. Ayer,et al.  Glucose sensing by MondoA:Mlx complexes: A role for hexokinases and direct regulation of thioredoxin-interacting protein expression , 2008, Proceedings of the National Academy of Sciences.

[79]  Remco Dijkman,et al.  Novel and highly recurrent chromosomal alterations in Sézary syndrome. , 2008, Cancer research.

[80]  B. Lüscher,et al.  Inhibition of apoptosis by MAD1 is mediated by repression of the PTEN tumor suppressor gene , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  B Franz Lang,et al.  A phylogenomic investigation into the origin of metazoa. , 2008, Molecular biology and evolution.

[82]  J. Delrow,et al.  Drosophila growth and development in the absence of dMyc and dMnt. , 2008, Developmental biology.

[83]  Nicholas H. Putnam,et al.  The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans , 2008, Nature.

[84]  F. Calvo,et al.  c-Myc Inhibits Ras-Mediated Differentiation of Pheochromocytoma Cells by Blocking c-Jun Up-Regulation , 2008, Molecular Cancer Research.

[85]  Christopher Logothetis,et al.  Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesis. , 2008, Cancer biology & therapy.

[86]  J. Partanen,et al.  c-Myc Blazing a Trail of Death: Coupling of the Mitochondrial and Death Receptor Apoptosis Pathways by c-Myc , 2007, Cell cycle.

[87]  S. Amente,et al.  P-TEFb is a Crucial Co-Factor for Myc Transactivation , 2007, Cell cycle.

[88]  J. Girard,et al.  ChREBP, a transcriptional regulator of glucose and lipid metabolism. , 2007, Annual review of nutrition.

[89]  Nicola Zamboni,et al.  Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.

[90]  J. Haycock,et al.  c-Myc and ChREBP regulate glucose-mediated expression of the L-type pyruvate kinase gene in INS-1-derived 832/13 cells. , 2007, American journal of physiology. Endocrinology and metabolism.

[91]  R. Eisenman,et al.  The Function and Regulation of the JARID1 Family of Histone H3 Lysine 4 Demethylases: the Myc Connection , 2007, Cell cycle.

[92]  R. Eisenman,et al.  The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. , 2007, Genes & development.

[93]  J. Partanen,et al.  c‐Myc primed mitochondria determine cellular sensitivity to TRAIL‐induced apoptosis , 2007, The EMBO journal.

[94]  Xiao-ling Guo,et al.  Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia , 2007, Leukemia & lymphoma.

[95]  Y. Sham,et al.  A critical role for the loop region of the basic helix–loop–helix/leucine zipper protein Mlx in DNA binding and glucose-regulated transcription , 2006, Nucleic acids research.

[96]  H. Towle,et al.  ChREBP•Mlx Is the Principal Mediator of Glucose-induced Gene Expression in the Liver* , 2006, Journal of Biological Chemistry.

[97]  B. Jayaprakasam,et al.  Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity Published, JLR Papers in Press, June 21, 2006. , 2006, Journal of Lipid Research.

[98]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[99]  L. Penn,et al.  The Oscar-worthy role of Myc in apoptosis. , 2006, Seminars in cancer biology.

[100]  J. Repa,et al.  Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. , 2006, Cell metabolism.

[101]  S. R. Hann.  Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. , 2006, Seminars in cancer biology.

[102]  D. Ayer,et al.  MondoA-Mlx Heterodimers Are Candidate Sensors of Cellular Energy Status: Mitochondrial Localization and Direct Regulation of Glycolysis , 2006, Molecular and Cellular Biology.

[103]  Giacomo Finocchiaro,et al.  Myc-binding-site recognition in the human genome is determined by chromatin context , 2006, Nature Cell Biology.

[104]  Philip R. Gafken,et al.  Myc influences global chromatin structure , 2006, The EMBO journal.

[105]  M. Cole,et al.  A Conserved Myc Protein Domain, MBIV, Regulates DNA Binding, Apoptosis, Transformation, and G2 Arrest , 2006, Molecular and Cellular Biology.

[106]  Peng-hui Zhang,et al.  Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity. , 2006, Urology.

[107]  C. Glass,et al.  Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression. , 2006, Cancer research.

[108]  A. Wynshaw-Boris,et al.  Inflammatory Disease and Lymphomagenesis Caused by Deletion of the Myc Antagonist Mnt in T Cells , 2006, Molecular and Cellular Biology.

[109]  S. McMahon,et al.  Targeting of Miz-1 Is Essential for Myc-mediated Apoptosis* , 2006, Journal of Biological Chemistry.

[110]  P. Gallant.  Myc/Max/Mad in invertebrates: the evolution of the Max network. , 2006, Current topics in microbiology and immunology.

[111]  M. Cole,et al.  Transcriptional activation by the Myc oncoprotein. , 2006, Current topics in microbiology and immunology.

[112]  D. Ayer,et al.  The Mlx network: evidence for a parallel Max-like transcriptional network that regulates energy metabolism. , 2006, Current topics in microbiology and immunology.

[113]  N. Schreiber-Agus,et al.  Lessons learned from Myc/Max/Mad knockout mice. , 2006, Current topics in microbiology and immunology.

[114]  C. Grandori,et al.  Activation by c-Myc of transcription by RNA polymerases I, II and III. , 2006, Biochemical Society symposium.

[115]  M. Henriksson,et al.  Mnt transcriptional repressor is functionally regulated during cell cycle progression , 2005, Oncogene.

[116]  E. Wang,et al.  c‐Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts , 2005, Journal of cellular biochemistry.

[117]  P. Lavigne,et al.  Toward the elucidation of the structural determinants responsible for the molecular recognition between Mad1 and Max. , 2005, Biochemistry.

[118]  W. El-Deiry,et al.  Mxi1 is induced by hypoxia in a HIF-1–dependent manner and protects cells from c-Myc-induced apoptosis , 2005, Cancer biology & therapy.

[119]  B. Edgar,et al.  The Transcriptional Repressor dMnt Is a Regulator of Growth in Drosophila melanogaster , 2005, Molecular and Cellular Biology.

[120]  Kathryn A. O’Donnell,et al.  Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis , 2005, Molecular and Cellular Biology.

[121]  A. Wynshaw-Boris,et al.  Mnt–Max to Myc–Max complex switching regulates cell cycle entry , 2005, The Journal of cell biology.

[122]  H. Koeffler,et al.  Mxi1 isoforms are expressed in hematological cell lines and normal bone marrow. , 2005, International journal of oncology.

[123]  E. Kremmer,et al.  Mad1 Function in Cell Proliferation and Transcriptional Repression Is Antagonized by Cyclin E/CDK2* , 2005, Journal of Biological Chemistry.

[124]  H. Towle,et al.  Direct Role of ChREBP·Mlx in Regulating Hepatic Glucose-responsive Genes* , 2005, Journal of Biological Chemistry.

[125]  Carla Grandori,et al.  c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I , 2005, Nature Cell Biology.

[126]  S. Lowe,et al.  A conserved element in Myc that negatively regulates its proapoptotic activity , 2005, EMBO reports.

[127]  Katsumi Iizuka,et al.  Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[128]  J. Zavadil,et al.  Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene. , 2004, European journal of cancer.

[129]  Bruce J. Aronow,et al.  Chromatin Immunoprecipitation Assays Footprints in Glycolytic Genes by Evaluation of Myc E-box Phylogenetic Supplemental Material , 2004 .

[130]  J. S. Britton,et al.  dMyc is required for larval growth and endoreplication in Drosophila , 2004, Development.

[131]  R. Eisenman,et al.  Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome. , 2004, Human molecular genetics.

[132]  K. Iizuka,et al.  Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[133]  H. Towle,et al.  Mlx Is the Functional Heteromeric Partner of the Carbohydrate Response Element-binding Protein in Glucose Regulation of Lipogenic Enzyme Genes* , 2004, Journal of Biological Chemistry.

[134]  J. Cleveland,et al.  Mnt Loss Triggers Myc Transcription Targets, Proliferation, Apoptosis, and Transformation , 2004, Molecular and Cellular Biology.

[135]  John L Cleveland,et al.  Myc pathways provoking cell suicide and cancer , 2003, Oncogene.

[136]  A. Wynshaw-Boris,et al.  Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis , 2003, The EMBO journal.

[137]  D. Livingston,et al.  MYC recruits the TIP60 histone acetyltransferase complex to chromatin , 2003, EMBO reports.

[138]  Yvonne A. Evrard,et al.  c-Myc Transformation Domain Recruits the Human STAGA Complex and Requires TRRAP and GCN5 Acetylase Activity for Transcription Activation* , 2003, Journal of Biological Chemistry.

[139]  D. Scott,et al.  c-Myc Is Required for the Glucose-mediated Induction of Metabolic Enzyme Genes* , 2003, The Journal of Biological Chemistry.

[140]  S. Wright,et al.  Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc. , 2003, The Biochemical journal.

[141]  Stephen K. Burley,et al.  X-Ray Structures of Myc-Max and Mad-Max Recognizing DNA Molecular Bases of Regulation by Proto-Oncogenic Transcription Factors , 2003, Cell.

[142]  R. Eisenman,et al.  Direct activation of RNA polymerase III transcription by c-Myc , 2003, Nature.

[143]  Fionnuala Morrish,et al.  c-MYC apoptotic function is mediated by NRF-1 target genes. , 2003, Genes & development.

[144]  D. Ayer,et al.  A Novel Heterodimerization Domain, CRM1, and 14-3-3 Control Subcellular Localization of the MondoA-Mlx Heterocomplex , 2002, Molecular and Cellular Biology.

[145]  P. Farnham,et al.  Myc Recruits P-TEFb to Mediate the Final Step in the Transcriptional Activation of the cad Promoter* , 2002, The Journal of Biological Chemistry.

[146]  Yuko Hamada,et al.  Effect of the transcriptional repressor Mad1 on proliferation of human melanoma cells , 2002, Experimental dermatology.

[147]  Stuart L. Schreiber,et al.  Active genes are tri-methylated at K4 of histone H3 , 2002, Nature.

[148]  Carla Grandori,et al.  Modulation of T‐lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1 , 2002, The EMBO journal.

[149]  R. Eisenman,et al.  Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[150]  Stuart L. Schreiber,et al.  Methylation of histone H3 Lys 4 in coding regions of active genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[151]  David M. Livingston,et al.  A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells , 2002, Science.

[152]  James M. Roberts,et al.  MAD1 and p27KIP1 Cooperate To Promote Terminal Differentiation of Granulocytes and To Inhibit Myc Expression and Cyclin E-CDK2 Activity , 2002, Molecular and Cellular Biology.

[153]  M. Eilers,et al.  Contributions of Myc to tumorigenesis. , 2002, Biochimica et biophysica acta.

[154]  G. Finocchiaro,et al.  Mxi1 inhibits the proliferation of U87 glioma cells through down-regulation of cyclin B1 gene expression , 2002, British Journal of Cancer.

[155]  M. Henriksson,et al.  Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1 , 2002, Oncogene.

[156]  J. Massagué,et al.  Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. , 2002, Nature.

[157]  K. Uyeda,et al.  Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[158]  S. Korsmeyer,et al.  Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis , 2001, Molecular and Cellular Biology.

[159]  E. J. Fox,et al.  S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells. , 2001, The Biochemical journal.

[160]  M. Eilers,et al.  Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. , 2001, Genes & development.

[161]  D. Kahn,et al.  New members of the Drosophila Myc transcription factor subfamily revealed by a genome-wide examination for basic helix-loop-helix genes , 2001, Mechanisms of Development.

[162]  D. Wechsler,et al.  Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells , 2001, The Prostate.

[163]  J. Massagué,et al.  TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b , 2001, Nature Cell Biology.

[164]  J. Massagué,et al.  Repression of p15INK4b expression by Myc through association with Miz-1 , 2001, Nature Cell Biology.

[165]  Nikita Popov,et al.  Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[166]  A Ballabio,et al.  WBSCR14, a gene mapping to the Williams--Beuren syndrome deleted region, is a new member of the Mlx transcription factor network. , 2001, Human molecular genetics.

[167]  G. Evan,et al.  Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation , 2001, Oncogene.

[168]  R. Eisenman,et al.  Targeted Deletion of the S-Phase-Specific Myc Antagonist Mad3 Sensitizes Neuronal and Lymphoid Cells to Radiation-Induced Apoptosis , 2001, Molecular and Cellular Biology.

[169]  U. Weidle,et al.  The transcriptional program of a human B cell line in response to Myc. , 2001, Nucleic acids research.

[170]  D. Ayer,et al.  MondoA, a Novel Basic Helix-Loop-Helix–Leucine Zipper Transcriptional Activator That Constitutes a Positive Branch of a Max-Like Network , 2000, Molecular and Cellular Biology.

[171]  R. Eisenman,et al.  Solution Structure of the Interacting Domains of the Mad–Sin3 Complex Implications for Recruitment of a Chromatin-Modifying Complex , 2000, Cell.

[172]  C. Asker,et al.  Inhibition of cell growth and apoptosis by inducible expression of the transcriptional repressor Mad1. , 2000, Experimental cell research.

[173]  C. Dang,et al.  Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.

[174]  A. Reymond,et al.  Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway? , 2000, Oncogene.

[175]  C. Englert,et al.  Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. , 2000, Cancer research.

[176]  Young-Hwa Song,et al.  Identification of Mad as a repressor of the human telomerase (hTERT) gene , 2000, Oncogene.

[177]  T. Littlewood,et al.  Action of Myc in vivo - proliferation and apoptosis. , 2000, Current opinion in genetics & development.

[178]  M. Cole,et al.  An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. , 2000, Molecular cell.

[179]  M. Cole,et al.  The Essential Cofactor TRRAP Recruits the Histone Acetyltransferase hGCN5 to c-Myc , 2000, Molecular and Cellular Biology.

[180]  D. Ayer,et al.  Mlx, a Novel Max-like BHLHZip Protein That Interacts with the Max Network of Transcription Factors* , 1999, The Journal of Biological Chemistry.

[181]  N. Jenkins,et al.  Mga, a dual‐specificity transcription factor that interacts with Max and contains a T‐domain DNA‐binding motif , 1999, The EMBO journal.

[182]  R. Eisenman,et al.  Dwarfism and dysregulated proliferation in mice overexpressing the MYC antagonist MAD1. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[183]  Jun Liu,et al.  A 13-Amino Acid Amphipathic α-Helix Is Required for the Functional Interaction between the Transcriptional Repressor Mad1 and mSin3A* , 1999, The Journal of Biological Chemistry.

[184]  M. Roussel,et al.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. , 1999, Genes & development.

[185]  W. Ansorge,et al.  Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 , 1999, The EMBO journal.

[186]  J. Tonn,et al.  Analysis of the max‐binding protein MNT in human medulloblastomas , 1999, International journal of cancer.

[187]  D. Roop,et al.  Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis , 1999, Oncogene.

[188]  H. Sugimura,et al.  Mxi1 Mutations in Human Neurofibrosarcomas , 1999, Japanese journal of cancer research : Gann.

[189]  E. Reddy,et al.  The v-myc oncogene , 1999, Oncogene.

[190]  M. Cole,et al.  The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation , 1999, Oncogene.

[191]  G. Prendergast,et al.  Mechanisms of apoptosis by c-Myc , 1999, Oncogene.

[192]  Yong Hua Xu,et al.  mad-overexpression down regulates the malignant growth and p53 mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells , 1999, Cell Research.

[193]  M. Eilers,et al.  Control of cell proliferation by Myc family genes. , 1999, Molecules and cells.

[194]  L. Chin,et al.  Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation , 1999, Oncogene.

[195]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[196]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[197]  M. Cole,et al.  The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.

[198]  J L Cleveland,et al.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.

[199]  E. Prochownik,et al.  Commonly occurring loss and mutation of the MXI1 gene in prostate cancer , 1998, Genes, chromosomes & cancer.

[200]  R. DePinho,et al.  Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth , 1998, Nature.

[201]  H. Konishi,et al.  Molecular Analysis of a Myc Antagonist, ROX/Mnt, at 17p13.3 in Human Lung Cancers , 1998, Japanese journal of cancer research : Gann.

[202]  R. Eisenman,et al.  Sequential expression of the MAD family of transcriptional repressors during differentiation and development , 1998, Oncogene.

[203]  C. Dang,et al.  A unique glucose-dependent apoptotic pathway induced by c-Myc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[204]  B. Amati,et al.  Myc and the cell cycle. , 1998, Frontiers in bioscience : a journal and virtual library.

[205]  A. Giaccia,et al.  p53 mediates apoptosis induced by c-Myc activation in hypoxic or gamma irradiated fibroblasts , 1998, Cell Death and Differentiation.

[206]  R. Eisenman,et al.  Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation , 1998, The EMBO journal.

[207]  J. Serth,et al.  The MXI1 tumor suppressor gene is not mutated in primary prostate cancer. , 1998, Oncology reports.

[208]  D. Wechsler,et al.  MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. , 1997, Cancer research.

[209]  R. Bernards,et al.  Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity , 1997, Oncogene.

[210]  L. Larsson,et al.  Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells , 1997, Oncogene.

[211]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[212]  M. Hengstschläger,et al.  Cellular targets for activation by c-Myc include the DNA metabolism enzyme thymidine kinase. , 1997, DNA and cell biology.

[213]  E. Kremmer,et al.  Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity , 1997, Current Biology.

[214]  D. Ledbetter,et al.  Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non‐canonical E box and acts as a transcriptional repressor , 1997, The EMBO journal.

[215]  Wen‐Ming Yang,et al.  Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression , 1997, Cell.

[216]  C. Cultraro,et al.  Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation , 1997, Molecular and cellular biology.

[217]  R. DePinho,et al.  Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[218]  R. Eisenman,et al.  Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. , 1997, Genes & development.

[219]  R. Eisenman,et al.  Mnt: a novel Max-interacting protein and Myc antagonist. , 1997, Current topics in microbiology and immunology.

[220]  R. Eisenman,et al.  Myc and Max Homologs in Drosophila , 1996, Science.

[221]  R. Eisenman,et al.  Mad proteins contain a dominant transcription repression domain , 1996, Molecular and cellular biology.

[222]  M. Polymenis,et al.  An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc , 1996, Molecular and cellular biology.

[223]  D. Beach,et al.  Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.

[224]  M. Roussel,et al.  Inhibition of cell proliferation by the Mad1 transcriptional repressor , 1996, Molecular and cellular biology.

[225]  W. Ansorge,et al.  Activation of cyclin‐dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. , 1996, The EMBO journal.

[226]  P. Goodfellow,et al.  Mxi1 tumor suppressor gene is not mutated in primary pancreatic adenocarcinoma. , 1996, Cancer letters.

[227]  N. Copeland,et al.  Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. , 1996, The EMBO journal.

[228]  N. Copeland,et al.  Mad3 and Mad4: novel Max‐interacting transcriptional repressors that suppress c‐myc dependent transformation and are expressed during neural and epidermal differentiation. , 1995, The EMBO journal.

[229]  M. Pagano,et al.  Identification of a Myc‐dependent step during the formation of active G1 cyclin‐cdk complexes. , 1995, The EMBO journal.

[230]  H. Shih,et al.  Two CACGTG Motifs with Proper Spacing Dictate the Carbohydrate Regulation of Hepatic Gene Transcription (*) , 1995, The Journal of Biological Chemistry.

[231]  C. Seelos,et al.  Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. , 1995, Oncogene.

[232]  E. Ziff,et al.  The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max , 1995, Molecular and cellular biology.

[233]  R. DePinho,et al.  Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells , 1995, Nature Medicine.

[234]  R. Eisenman,et al.  Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[235]  P. Farnham,et al.  An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants , 1995, Molecular and cellular biology.

[236]  R. Eisenman,et al.  Mad-max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3 , 1995, Cell.

[237]  L. Chin,et al.  An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the Yeast Transcriptional Repressor SIN3 , 1995, Cell.

[238]  K. Alitalo,et al.  Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro , 1995, The Journal of cell biology.

[239]  Arthur R. Brothman,et al.  Mutation of the MXI1 gene in prostate cancer , 1995, Nature Genetics.

[240]  R. DePinho,et al.  Erratum: Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells (Nature Medicine (1995) 1 (638-643)) , 1995 .

[241]  S. Mai,et al.  Overexpression of c-myc precedes amplification of the gene encoding dihydrofolate reductase. , 1994, Gene.

[242]  C. Ling,et al.  Transfected c-myc and c-Ha-ras modulate radiation-induced apoptosis in rat embryo cells. , 1994, Radiation research.

[243]  R. DePinho,et al.  Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[244]  L. Larsson,et al.  Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. , 1994, Oncogene.

[245]  R. Eisenman,et al.  The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes. , 1994, Cold Spring Harbor symposia on quantitative biology.

[246]  R. Eisenman,et al.  A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. , 1993, Genes & development.

[247]  Stephen K. Burley,et al.  Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain , 1993, Nature.

[248]  N. Hay,et al.  Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2 , 1993, Molecular and cellular biology.

[249]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[250]  R. Brent,et al.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.

[251]  Bruno Amati,et al.  Oncogenic activity of the c-Myc protein requires dimerization with Max , 1993, Cell.

[252]  R. Eisenman,et al.  Regulation of Myc: Max complex formation and its potential role in cell proliferation. , 1992, The Tohoku journal of experimental medicine.

[253]  R. Eisenman,et al.  Myc and Max proteins possess distinct transcriptional activities , 1992, Nature.

[254]  R. Eisenman,et al.  Myc and Max function as a nucleoprotein complex , 1992, Current Biology.

[255]  M. Cole,et al.  Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. , 1992, Genes & development.

[256]  J. Cleveland,et al.  c-myc transactivates the ornithine decarboxylase gene. , 1992, Current topics in microbiology and immunology.

[257]  R. Eisenman,et al.  Myc and Max associate in vivo. , 1992, Genes & development.

[258]  C. Dang,et al.  Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization , 1991, Molecular and cellular biology.

[259]  G. Prendergast,et al.  Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. , 1991, Science.

[260]  R. Eisenman,et al.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. , 1991, Science.

[261]  G. Inghirami,et al.  Negative autoregulation of c‐myc gene expression is inactivated in transformed cells. , 1990, The EMBO journal.

[262]  R. Eisenman,et al.  New light on Myc and Myb. Part II. Myb. , 1990, Genes & development.

[263]  H. Weintraub,et al.  Sequence-specific DNA binding by the c-Myc protein. , 1990, Science.

[264]  L. Penn,et al.  C-MYC: evidence for multiple regulatory functions. , 1990, Seminars in cancer biology.

[265]  R. Eisenman,et al.  New light on Myc and Myb. Part I. Myc. , 1990, Genes & development.

[266]  M. Schwab,et al.  Suppression of MYC by high expression of NMYC in human neuroblastoma cells , 1989, Journal of neuroscience research.

[267]  David Baltimore,et al.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.

[268]  A. W. Harris,et al.  N‐myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross‐regulation with c‐myc. , 1989, The EMBO journal.

[269]  A. Ogura,et al.  Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line , 1985, Nature.

[270]  M. Greenberg,et al.  Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. , 1985, The Journal of biological chemistry.

[271]  J. Battey,et al.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer , 1985, Nature.

[272]  D. Bar-Sagi,et al.  Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation , 1985, Cell.

[273]  G. Evan,et al.  Metabolism of c‐myc gene products: c‐myc mRNA and protein expression in the cell cycle. , 1985, EMBO Journal.

[274]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[275]  F. Alt,et al.  Transposition and amplification of oncogene-related sequences in human neuroblastomas , 1983, Cell.

[276]  J. Trent,et al.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.

[277]  C. Croce,et al.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[278]  P. Leder,et al.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[279]  M. Groudine,et al.  Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line , 1982, Nature.

[280]  B. Vennstrom,et al.  Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29 , 1982, Journal of virology.

[281]  J. Bishop,et al.  DNA and RNA from Uninfected Vertebrate Cells Contain Nucleotide Sequences Related to the Putative Transforming Gene of Avian Myelocytomatosis Virus , 1979, Journal of virology.